Other languages Nuvalent, Inc.

Equities

NUVL

US6707031075

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
66.86 ^USD	+1.20%		+6.53%	-9.15%

17/04	Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing	MT
17/04	Jefferies Initiates Nuvalent With Buy Rating, $97 Price Target	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing	18/04
Nuvalent Insider Sold Shares Worth $2,566,479, According to a Recent SEC Filing	11/04
Nuvalent Insider Sold Shares Worth $1,654,311, According to a Recent SEC Filing	01/04
Nuvalent Insider Sold Shares Worth $3,032,528, According to a Recent SEC Filing	28/03
Nuvalent Insider Sold Shares Worth $1,550,229, According to a Recent SEC Filing	26/03
Nuvalent's Non-Small Cell Lung Cancer Drug Candidate Gets FDA Breakthrough Therapy Designation	27/02
Nuvalent, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Nuvalent, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Nuvalent Starts Phase 2 Part of Clinical Trial of Potential Lung Cancer Treatment	12/02
Nuvalent, Inc. Initiates the Phase 2 Portion of Alkove-1 Clinical Trial for Patients with Alk-Positive Nsclc and Other Solid Tumors	12/02
Nuvalent Outlines Three-Year Product Plan	08/01
Nuvalent Insider Sold Shares Worth $378,350, According to a Recent SEC Filing	21/12
Nuvalent Insider Sold Shares Worth $2,274,600, According to a Recent SEC Filing	21/12
Nuvalent Insider Sold Shares Worth $2,880,548, According to a Recent SEC Filing	21/12
Nuvalent Insider Sold Shares Worth $3,032,800, According to a Recent SEC Filing	21/12
Nuvalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Nuvalent Insider Sold Shares Worth $157,975, According to a Recent SEC Filing	04/11
Nuvalent Insider Sold Shares Worth $4,648,872, According to a Recent SEC Filing	27/23/27
Nuvalent Prices Stock Offering at $56 a Share	17/23/17
Nuvalent Reports 'Encouraging' Preliminary Activity Analysis in Phase 1 Trial of Cancer Drug Candidate NVL-655	13/23/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nuvalent, Inc.

Equities

NUVL

US6707031075

Other languages

Filters